Christopher G Fielding, DDS

Dr. Berman is an anesthesiologist specializing in high-risk obstetric anesthesiology, anesthesia for fetal surgery, general adult anesthesiology, and medical education. Additionally, he serves as assistant program director of the anesthesiology residency program at Johns Hopkins.He attended medical school at the Icahn School of Medicine at Mount Sinai and elected to remain at Mount Sinai for his anesthesiology residency. During medical school, he was awarded the Jagust award for highest-performing medical student in anesthesiology and went on to be selected by his peers for induction in the Gold Humanism Honor Society. He was a member of the Eliasberg Research Program and the clinician-educator track as a resident.He then completed a fellowship in obstetric, gynecologic and fetal anesthesia at Johns Hopkins, where he received numerous clinical and teaching awards. He subsequently joined the Department of Anesthesiology and Critical Care Medicine as full-time faculty.Since joining ACCM, Dr. Berman has been appointed assistant program director of the anesthesiology residency and received the Rising Faculty Award, the Beattie Teacher of the Year Award several times, and the Most Innovative Faculty award. He was also awarded the Society for Obstetric Anesthesia and Perinatology Teacher of the Year Award. He is a core member of the hepatobiliary anesthesia team, performing complex hepatobiliary procedures on a regular basis. He also serves as a phone consultant for the Malignant Hyperthermia Hotline.Dr. Berman has a special interest in cardiac disease in pregnancy and the use of peripartum and perioperative echocardiography. He serves on a variety of national and international committees In the anesthesiology community. He is currently pursuing an MEHP from the Johns Hopkins School of Education. His research interests include personal financial literacy among physicians, curriculum design/development and medical student & resident education.

Dr. James T. Castle earned his D.D.S. from Creighton University School of Dentistry and his certificate in Oral & Maxillofacial at the Naval Dental School. He completed a Callendar-Binford Fellowship in Otorhinolaryngic, Head and Neck Pathology at the Armed Forces Institute of Pathology and received a Master’s degree from The George Washington University. A past Chairman and Residency Program Director of the Oral & Maxillofacial Pathology Department at the Naval Postgraduate Dental School, Dr. Castle is additionally a Fellow of the American Academy of Oral and Maxillofacial Pathology and a Diplomate of the American Board of Oral and Maxillofacial Pathology. He completed a 30-year career in the United States Navy Dental Corps retiring at the rank of Captain.

Dr. B. Douglas Smith is an Oncologist in Baltimore caring for patients with leukemias and other blood and bone marrow disorders and he is recognized nationally as an expert in the care of patients with these disorders and as a leader in novel therapeutics for these conditions. Dr. Smith serves as the Co-Director of Clinical Research Operations for the Division of Hematologic Malignancies and helps to manage the Division’s clinical research trials.Dr. Smith received his undergraduate degree in Biology from Lafayette College (Easton, PA), earned his M.D. at the Medical College of Pennsylvania (Philadelphia, PA), completed his Residency at Strong Memorial Hospital of the University of Rochester (Rochester, NY), and Fellowship in Medical Oncology at Johns Hopkins (Baltimore, MD). Dr. Smith joined the Johns Hopkins faculty in 1998 at the completion of his training.His main research interests include drug development for patients with AML, CML, and MDS and he serves as Co-Investigator for the Oncology Center’s UM1 (early phase drug development) Grant. The Leukemia Program’s clinical trials portfolio has included trials for each of the 8 newly FDA-approved drugs for acute leukemia in the past 2 years. Dr. Smith has a passion for teaching trainees and has served on the Fellowship Executive Committee since 2010 focusing on the program’s educational platforms. He has won numerous teaching awards in both the Department of Oncology and the Department of Medicine multiple times, and he has a track record of mentoring fellows pursuing clinical-translational research and clinician-educator pathways. In 2020, Dr. Smith was awarded membership in the prestigious Miller Coulson Academy for Excellence in Clinical Care.He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American Association for Cancer Research. He has served on the National Comprehensive Cancer Network guideline panel for CML since 2001 and previously served on the AML panel from 2001-2015. Dr. Smith has extensive experience in the regulatory aspects of drug development and he currently serves as the Chair of the Johns Hopkins Institutional Review Board #2.